Medline

MDLN · NASDAQ

$35.46+$0.27 (+0.77%)TodayMarket closed ·
Prev close $35.19

Latest news

  • Press releaseGlobe Newswire

    MDLN Investigation Reminder: Medline Investors that Lost Money after the 13% Stock Drop are Notified to Contact BFA Law

  • Press releaseGlobe Newswire

    MDLN Securities Announcement: Medline Investors with Losses may have Rights in an Ongoing Securities Fraud Investigation – Contact BFA Law

  • Press releasePRNewswire

    Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

  • Press releaseGlobe Newswire

    $MDLN Investors: A Securities Fraud Investigation is Pending on behalf of Medline Investors that Lost Money after 13% Stock Drop – Contact BFA Law

  • Press releaseNewsfile

    Medline Inc. Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money On Your MDLN Investments

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

  • Press releasePRNewswire

    MDLN Stock Alert: Medline Product Quality Issues and Subsequent 13% Stock Drop Trigger Securities Fraud Investigation for Investors

  • Press releasePRNewswire

    Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care

  • Press releaseGlobe Newswire

    MDLN Investigation News: The Medline Securities Fraud Investigation into 13% Stock Drop is Pending – Investors Notified to Contact BFA Law

  • Press releaseGlobe Newswire

    MDLN Securities Alert: Lose Money on Your Medline Investment? BFA Law Notifies Investors of the Ongoing Securities Fraud Investigation over Product Quality Issues

  • Press releaseNewsfile

    MDLN ALERT: Kaplan Fox & Kilsheimer LLP is Investigating Medline Inc. (MDLN) for Potential Securities Law Violations

  • Press releaseGlobe Newswire

    MDLN Investor Reminder: BFA Law Reminds Medline Investors that Lost Money when Stock Dropped 13% of the Ongoing Securities Fraud Investigation

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Medline Inc. - MDLN

  • Press releaseNewsfile

    Kaplan Fox is Investigating Medline Inc. (MDLN) for Investors Who Suffered Losses

  • Press releaseBusiness Wire

    MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop

  • Press releasePRNewswire

    MDLN Stock Notice: Medline Stock Plummeted 13% after Product Quality Issues Disclosed - Securities Fraud Investigation Underway

  • Press releaseNewsfile

    Kaplan Fox Urges Investors of Medline Inc. (MDLN) with Losses to Contact the Firm

  • Press releaseGlobe Newswire

    Bragar Eagel & Squire, P.C. is Investigating Medline Inc. on Behalf of Medline Stockholders and Encourages Investors to Contact the Firm

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

  • Press releaseNewsfile

    Kaplan Fox Reminds Investors of Medline Inc. (MDLN) of an Ongoing Securities Investigation

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

  • Press releasePRNewswire

    Medline Legal Alert: Medline (MDLN) Investors who Lost Money are Notified of the Ongoing Securities Fraud Investigation

  • Press releaseGlobe Newswire

    MEDLINE INC. INVESTIGATION: MDLN Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

  • Press releaseNewsfile

    Kaplan Fox is Investigating Medline Inc. (MDLN) on Behalf of Shareholders for Possible Securities Law Violations

  • Press releaseNewsfile

    Kaplan Fox Advises Investors of Medline Inc. (MDLN) to Contact the Firm Regarding a Securities Investigation

  • Press releaseNewsfile

    Kaplan Fox Notifies Investors of Medline Inc. (MDLN) of a Securities Law Investigation

  • Press releaseBusiness Wire

    MDLN Stock Drop Alert: Medline Inc.’s Stock Drops 13% over Product Quality Issues Triggering Securities Fraud Investigation by BFA Law

  • Press releaseNewsfile

    Kaplan Fox Encourages Medline Inc. (MDLN) Investors to Contact the Firm Regarding a Securities Investigation

  • Press releaseNewsfile

    Kaplan Fox Alerts Investors of Medline Inc. (MDLN) to a Securities Law Investigation

  • NewsVandana Singh

    Medline Convenience Kits Impacted By Contamination In Recalled Becton Dickinson Products

  • Press releaseGlobe Newswire

    Medline Reports Second Quarter and First Six Months 2026 Results

  • Press releasePRNewswire

    MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations

  • NewsAvi Kapoor

    Jim Cramer: 'Go For' AST SpaceMobile, Power Plant Maker 'Too Speculative'

  • Press releaseGlobe Newswire

    MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations

  • NewsVandana Singh

    Medline Distribution Center Fire Creates Near-Term Headwind: Analyst

  • Press releaseGlobe Newswire

    MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update

  • News

    Medline Q1 2026 Earnings Call: Complete Transcript

  • Press releaseGlobe Newswire

    Medline Reports First Quarter 2026 Results

  • NewsVandana Singh

    FDA Flags Quality System Lapses At Medline Facility Over Device Risks

  • NewsCaroline Ryan

    Blackstone, Carlyle, Hellman & Friedman Offer 75M Shares For Medline

  • Press releaseGlobe Newswire

    Medline Reports Fourth Quarter and Full Year 2025 Results

  • News

    A Look Into Medline Inc's Price Over Earnings

  • NewsAvi Kapoor

    This Netflix Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.